Sionna Therapeutics, Inc. · NASDAQ:SION

Orbimed Advisors LLC reported a 8.40% stake in Sionna Therapeutics, Inc. (Schedule 13D)

Event Feb 10, 2025 · Filed Feb 13, 2025

Orbimed Advisors LLC reported a 8.40% stake in Sionna Therapeutics, Inc., 3,704,959 shares, with active intent on Feb 10, 2025. Filed Feb 13, 2025 (Schedule 13D).

Stake
8.40%
Shares
3,704,959
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC8.40%3,704,959
OrbiMed Capital GP VIII LLC8.40%3,704,959

Source

View original at SEC

Related